Search Results 51-60 of 19752 for celiac disease

1. Mayo Clinic Minute: The Truth About Gluten

   gluten free written on a chalkboard with bread, pasta and vegetables May is Celiac Awareness Month, and the Celiac Disease Foundation wants to make the ...

2. Predicting Intestinal Healing in Celiac Disease

   Hello, my name is Joe Murray. I'm a gastroenterologist in the Celiac Disease Program at Mayo Clinic. One of the challenges of following our patients with ...

3. Hepatitis B Immunity Check Needed for Newly Diagnosed Celiac Disease? - Mayo Clinic News Network

   Patients with celiac disease have the same hepatitis B rate of immunity after vaccination and risk of infection as the general public, according to a recent ...

4. Study of the Safety, Tolerability, Pharmacokinetics and Biomarker of DONQ52 in Celiac Disease Patients - Mayo Clinic

   Furthermore, to characterize the DONQ52 PK profile following single and multiple subcutaneous (SC) dose(s) in celiac disease patients and to investigate the ...

5. Celiac Awareness Month / Physician Burnout / Women's National Checkup Day: Mayo Clinic Radio

   Celiac disease is an immune reaction to eating gluten, a protein found in wheat, barley and rye. Over time, this immune reaction produces inflammation that ...

6. Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients - Mayo Clinic

   To determine the effects of 12 weeks administration of different dose levels of ALV003 on the mucosal lining of the small intestine and symptoms in celiac ...

7. A Study of Simvastatin Metabolism as a Test for Celiac Disease Activity - Mayo Clinic

   ... celiac disease. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns.

8. Functional Gastrointestinal Disease, Celiac Disease, and Non-celiac Gluten Sensitivity in an Olmsted County Cohort - Mayo Clinic

   ... celiac gluten sensitivity and functional gastrointestinal diseases (FGIDs). lso assess Diagnoses and lab values associated with celiac disease, NCGS, and ...

9. A Phase 2a/b Study of the Efficacy and Safety of Subcutaneous Amlitelimab in Adults With Nonresponsive Celiac Disease - Mayo Clinic

   The purpose of this study is to evaluate the efficacy and safety of amlitelimab in adult participants with non-responsive celiac disease (NRCD) who are on a ...

10. VTP-1000 in celiac disease - Clinical Trials

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...